About Diagnostic Ansers
Diagnostic Ansers is a Healthcare company based in Washington (United States) founded in 2012. SERS-active nanoparticles are developed for diagnostics and chemical detection. It operates in the Healthcare and Technology sectors. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
Diagnostic Ansers was founded in 2012 and focuses on the diagnostics and trace chemical detection sector. Ink-jet printed surface enhanced Raman spectroscopy (SERS)-active substrates are developed and marketed for these applications. Surface plasmon resonant spherical gold and silver nanoparticles are provided as bases for SERS measurements. Sensors are employed in swab and dipstick formats to identify traces of explosives, narcotics, and contaminants.
- Headquarters Washington, United States
- SectorsHealthcareTechnology
- Email••••••••
- Website diagnosticansers.com
- Social LinkedIn X
- Latest Funding Round$5K (USD), Grant
Jun 2016
- InvestorsJenoptik
& 1 more
Funding Insights of Diagnostic Ansers
- Total Rounds 3
- Last Round Grant — $5,000
- First Round $150,000
(Jul 2015)
- Investors Count 2
All 3 funding rounds of Diagnostic Ansers with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | $5,000 | Grant | – | – | |
| Jul 2015 | $150,000 | Grant | – | – | |
| Jul 2015 | $150,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Diagnostic Ansers
Diagnostic Ansers has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Jenoptik and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of products and services for photonics market | 1991 | jenoptik.com | Jena, Germany | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Diagnostic Ansers
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Diagnostic Ansers
3 dated milestones of Diagnostic Ansers across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Diagnostic Ansers is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Grant, of $5K.
Competitors of Diagnostic Ansers
Diagnostic Ansers has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of Diagnostic Ansers
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Diagnostic Ansers (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Diagnostic Ansers
Diagnostic Ansers was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Diagnostic Ansers is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
Diagnostic Ansers was founded in 2012 and focuses on the diagnostics and trace chemical detection sector. Ink-jet printed surface enhanced Raman spectroscopy (SERS)-active substrates are developed and marketed for these applications. Surface plasmon resonant spherical gold and silver nanoparticles are provided as bases for SERS measurements. Sensors are employed in swab and dipstick formats to identify traces of explosives, narcotics, and contaminants.
Diagnostic Ansers's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Diagnostic Ansers has 2 investors. Key investors include Jenoptik, and National Science Foundation.